Trends in CRISPR-Cas9 technology application in cancer

Area of Science:

• Oncology
• Genetics
• Biotechnology

Background:

• CRISPR-Cas9 technology offers significant potential for advancing cancer research and treatment.
• Current pre-clinical applications of CRISPR in oncology are in early stages, with many questions regarding efficacy and safety.
• CRISPR-Cas9 is a precise, cost-effective, and high-throughput gene-editing tool.

Purpose of the Study:

• To explore the potential applications of CRISPR-Cas9 in cancer research.
• To identify and discuss the challenges and risks associated with CRISPR-Cas9 in cancer therapy.
• To highlight the current status of CRISPR engineering for cancer treatment translation.

Main Methods:

• Review of current CRISPR-Cas9 applications in pre-clinical cancer research.
• Analysis of the benefits and limitations of CRISPR technology in oncology.
• Discussion of potential risks, including immune response and off-target effects.

Main Results:

• CRISPR-Cas9 demonstrates high specificity, economic sustainability, and high throughput capabilities.
• Potential risks include toxic immune responses to Cas protein and off-target mutations.
• Challenges exist in delivering edited cells back to cancer patients.

Conclusions:

• CRISPR-Cas9 holds great promise for the future of oncology.
• Addressing safety concerns, precision, and delivery methods is crucial for clinical translation.
• Further research is essential to overcome the perils and harness the possibilities of CRISPR in cancer therapy.